Can creatine supplementation form carcinogenic heterocyclic amines in humans?

Abstract

There is a long-standing concern that creatine supplementation could be associated with cancer, possibly by facilitating the formation of carcinogenic heterocyclic amines (HCAs). This study provides compelling evidence that both low and high doses of creatine supplementation, given either acutely or chronically, does not cause a significant increase in HCA formation. HCAs detection was unrelated to creatine supplementation. Diet was likely to be the main factor responsible for HCAs formation after either placebo (n = 6) or creatine supplementation (n = 3). These results directly challenge the recently suggested biological plausibility for the association between creatine use and risk of testicular germ cell cancer. Creatine supplementation has been associated with increased cancer risk. In fact, there is evidence indicating that creatine and/or creatinine are important precursors of carcinogenic heterocyclic amines (HCAs). The present study aimed to investigate the acute and chronic effects of low- and high-dose creatine supplementation on the production of HCAs in healthy humans (i.e. 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (8-MeIQx), 2-amino-(1,6-dimethylfuro[3,2-e]imidazo[4,5-b])pyridine (IFP) and 2-amino-3,4,8-trimethylimidazo[4,5-f]quinoxaline (4,8-DiMeIQx)). This was a non-counterbalanced single-blind crossover study divided into two phases, in which low- and high-dose creatine protocols were tested. After acute (1 day) and chronic supplementation (30 days), the HCAs PhIP, 8-MeIQx, IFP and 4,8-DiMeIQx were assessed through a newly developed HPLC-MS/MS method. Dietary HCA intake and blood and urinary creatinine were also evaluated. Out of 576 assessments performed (from 149 urine samples), only nine (3 from creatine and 6 from placebo) showed quantifiable levels of HCAs (8-MeIQx: n = 3; 4,8-DiMeIQx: n = 2; PhIP: n = 4). Individual analyses revealed that diet rather than creatine supplementation was the main responsible factor for HCA formation in these cases. This study provides compelling evidence that both low and high doses of creatine supplementation, given either acutely or chronically, did not cause increases in the carcinogenic HCAs PhIP, 8-MeIQx, IFP and 4,8-DiMeIQx in healthy subjects. These findings challenge the long-existing notion that creatine supplementation could potentially increase the risk of cancer by stimulating the formation of these mutagens.

• Authors: Renato Tavares dos Santos Pereira, Felipe Augusto Dörr, Ernani Pinto, Marina Yazigi Solis, Guilherme Giannini Artioli, Alan Lins Fernandes, Igor Hisashi Murai, Wagner Silva Dantas, Antônio Carlos Seguro, Mirela Aparecida Rodrigues Santinho, Hamilton Roschel, Alain Carpentier, Jacques Remi Poortmans, Bruno Gualano
• Journal: The Journal of physiology (J Physiol) Vol. 593 Issue 17 Pg. 3959-71 (Sep 01 2015) ISSN: 1469-7793 [Electronic] England
• PMID: 26148133 (Publication Type: Controlled Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: © 2015 The Authors. The Journal of Physiology © 2015 The Physiological Society.

Chemical References

• 2-amino-(1,6-dimethylfuro(3,2-e)imidazo(4,5-b))pyridine
• Amines
• Carcinogens
• Furans
• Imidazoles
• Quinoxalines
• 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline
• 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine
• Creatine
• 3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine

Topics

• Adult
• Amines
• Carcinogens (metabolism)
• Creatine (blood, pharmacokinetics, urine)
• Cross-Over Studies
• Diet
• Female
• Furans (urine)
• Humans
• Imidazoles (urine)
• Male
• Quinoxalines (urine)
• Single-Blind Method